New Large-Scale Trial Results Show Stiolto® Respimat® Prevents COPD Exacerbations Better Than Spiriva® Respimat®; FDA recently accepted sNDA filing to review data from DYNAGITO trial for inclusion in Stiolto Respimat label

Media coverage

• Title	New Large-Scale Trial Results Show Stiolto® Respimat® Prevents COPD Exacerbations Better Than Spiriva® Respimat®; FDA recently accepted sNDA filing to review data from DYNAGITO trial for inclusion in Stiolto Respimat label
  Media name/outlet	PR Newswire
  Country	United States
  Date	3/29/18
  Persons	Antonio R Anzueto

• Title	New Large-Scale Trial Results Show Stiolto® Respimat® Prevents COPD Exacerbations Better Than Spiriva® Respimat®; FDA recently accepted sNDA filing to review data from DYNAGITO trial for inclusion in Stiolto Respimat label
  Media name/outlet	PR Newswire
  Country	United States
  Date	3/29/18
  Persons	Antonio R Anzueto